Fierce Biotech December 11, 2023
Medtronic is doubling down on its artificial intelligence partnership with Cosmo Pharmaceuticals, developer of plug-in software for automatically spotting health issues during endoscopic exams.
Cosmo previously obtained a landmark clearance from the FDA for its GI Genius system, which highlights polyps and potentially cancerous lesions in real time during a colonoscopy, including those the human eye might miss. Compatible with all agency-approved endoscopy video systems, GI Genius has been distributed exclusively by Medtronic since 2021.
Now, the medtech giant plans to expand its collaboration, with the goal of building a platform capable of hosting multiple AI-powered diagnostics gathered from third-party developers.
In exchange for its efforts—and continued global commercial rights—Cosmo could collect as much as $200 million or...
Today's Sponsors
Today's Sponsor
